KBI's leadership team has a wide range of CRO experience in working with the world major pharmaceutical industry. Our strong R&D and service capacity is solidly built on the strong expertise of the core members. In KBI’s working force, 5 members are medically trained doctors (MD in China, USA and Philipines), 4 with PhD Degree (China, USA, Australia and Germany), 14 with Master’s Degree; 11 with licenses of National Veterinary Licensed Examination, 5 with working experience in pharmaceutical industry or CRO (USA, Australia, Singapore), 6 people have worked in biomedical R & D for more than 20 years, and 6 people have overseas education or training experience. All 5 former and current Chief Executive Officers and Chief Scientific Officer have the PhD training and working experience overseas. KBI’s operation skills and quality awareness are seamlessly matched with the system of world-leading pharmaceutical industry and subject to regular inspections from AALAC and clients from different countries. We are also very proud of recognition in the client’s publications in top scientific journals (including Cell Metab, Diabetes, Diab Obes Metab) and invited presentations in the relevant fields (including AASLD 2017, Keystone Meeting 2019, NASH Summits in 2019 and 2021).